In ₹ Crore except Per Share Latest Annual | GUJTHEM FY26 | RPGLIFE FY26 | GUFICBIO FY26 | ORCHPHARMA FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | — | 153.76× | ◆ 66.84× | 249.38× | 153.76× | |
| P/B | 16.28× | 7.59× | 6.45× | ◆ 3.98× | 6.45× +152% | |
| EV/EBITDA | 64.11× | ◆ 29.80× | 30.48× | 133.07× | 30.48× +110% | |
| Market Cap | ₹4,685 Cr | ₹4,597 Cr | ₹4,290 Cr | ₹5,123 Cr | ₹4,597 Cr +2% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | — | — | 6.81% | 6.81% | |
| Revenue CAGR 5Y | — | — | — | 12.51% | 12.51% | |
| Net Income CAGR 3Y | — | — | — | -23.73% | -23.73% | |
| Revenue YoY (latest Q) | 22.07% | — | 16.58% | ◆ 75.89% | 46.23% -52% | |
| Net Income YoY (latest Q) | 22.12% | — | ◆ 70.71% | -78.38% | -3.84% +677% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 45.55% | 20.79% | 16.03% | 5.07% | 16.03% +184% | |
| Net Income Margin | ◆ 28.15% | 16.28% | 6.80% | 2.53% | 6.80% +314% | |
| Return on Common Equity | 16.22% | ◆ 19.02% | 9.66% | 1.60% | 9.66% +68% | |
| Return on Capital Employed | 14.76% | ◆ 19.86% | 14.61% | 0.35% | 14.61% +1% | |
| Return on Assets | 9.27% | ◆ 14.52% | 4.78% | 1.08% | 4.78% +94% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.56× | ◆ 0.03× | 0.58× | 0.28× | 0.28× +100% | |
| Interest Coverage | 21.23× | ◆ 141.13× | 3.29× | 0.43× | 3.29× +545% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹166 Cr | ₹708 Cr | ₹944 Cr | ₹811 Cr | ₹811 Cr -80% | |
| Net Income | ₹46.7 Cr | ₹115 Cr | ₹64.2 Cr | ₹20.5 Cr | ₹64.2 Cr -27% | |
| Total Assets | ₹503 Cr | ₹793 Cr | ₹1,342 Cr | ₹1,911 Cr | ₹1,342 Cr -62% | |
| EPS | ₹0 | ₹18.08 | ₹6.4 | ₹4.05 | ₹6.4 -100% | |
| Book Value per Share | ₹26.41 | ₹366.07 | ₹66.31 | ₹253.91 | ₹253.91 -90% | |